See All Slides - tctmd.com

Slides

Presentation THT 2026

Pulmonary Artery Banding to Unload the LV: The RESTORE Medical Study

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

Extra-Cardiac Compression for Severe Cardiogenic Shock

Presenter: Mitchell W. Krucoff

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT 2026

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Presenter: Stephen Wildhirt

March 03, 2026

Presentation THT 2026

Venstramedical: A Novel Low Profile Full Flow pVAD

Presenter: Suku T. Thambar

March 03, 2026

Presentation THT 2026

BioVentrix: Revival of the REVIVE-HF Study

Presenter: Ori Ben-Yehuda

March 03, 2026

Presentation THT 2026

Passive Smartwatch-Derived Physiology Predicts Biomarker-Defined Instability in Ambulatory HFrEF: Results From the TRIBE-HF II Study

Presenter: Rohan Goswami

March 03, 2026

Presentation THT 2026

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Presenter: Neal Patel

March 03, 2026

Presentation THT 2026

The Vitalyst pVAD

Presenter: Robert W. Yeh

March 03, 2026

Presentation THT 2026

Cardiac Dimensions - EMPOWER Trial

Presenter: Scott M. Lilly

March 03, 2026

Advertisement

Slides

Pulmonary Artery Banding to Unload the LV: The RESTORE Medical Study

Extra-Cardiac Compression for Severe Cardiogenic Shock

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection Fraction

Venstramedical: A Novel Low Profile Full Flow pVAD

BioVentrix: Revival of the REVIVE-HF Study

Passive Smartwatch-Derived Physiology Predicts Biomarker-Defined Instability in Ambulatory HFrEF: Results From the TRIBE-HF II Study

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

The Vitalyst pVAD

Cardiac Dimensions - EMPOWER Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content